DOI:
10.1055/s-00000025
Hormone and Metabolic Research
LinksClose Window
References
Hong DS, DuBois SG, Kummar S. et al.
Larotrectinib in patients with TRK fusion-positive solid tumours: A pooled
analysis of three phase 1/2 clinical trials.
Lancet Oncol 2020;
21: 531-540
We do not assume any responsibility for the contents of the web pages of other providers.